2m 2m 2m 2m 2m 2m 2m
MANNKIND (MNKD)
NASDAQ
$3.77+$0.02 (+0.43%)
Price as of Sep 11, 2026 7:59 PM EDT- $1.2BMarket Cap
- -32.68%1-Year Change
- BiotechnologyIndustry
MANNKIND (MNKD)
$3.77+$0.02 (+0.43%)
MNKD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.75 | ||
Change | -$0.04 (-1.06%) | ||
Open | $3.83 | ||
High | $3.85 | ||
Low | $3.73 | ||
Previous Close | $3.79 | ||
Volume | 2,469,876 | ||
30-Day Average Volume | 3,251,611 | ||
1-Week Change | -7.64% | ||
1-Month Change | -2.34% | ||
1-Year Change | -32.68% | ||
3-Year Change | -13.79% | ||
5-Year Change | -20.21% | ||
Fundamentals | |||
Shares Outstanding | 321.5M | ||
Total Assets | $732.3M | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $42.0M | ||
Net Income | -$19.0M | ||
Free Cash Flow | -$23.5M | ||
EBIT | -$4.3M | ||
EBITDA | $2.1M | ||
Net Working Capital | $102.8M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | 726 | ||
Enterprise Value/Revenue | 36 | ||
P/B | -18 | ||
P/E | -63 | ||
PEG | 3 | ||
Price/Free Cash Flow | -51 | ||
Price/Operating Cash Flow | -66 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 03/03/2017 | ||
Earnings & Revenue